🔎 Trials Near Me

Nyumbani › Kisukari cha Aina ya 1 › Tennessee

Majaribio ya kliniki ya Kisukari cha Aina ya 1 katika jimbo la Tennessee

Masomo 11 ya Kisukari cha Aina ya 1 yanatafuta washiriki katika vituo vya jimbo la Tennessee.

Miji katika jimbo la Tennessee

Maandishi rasmi ya utafiti (Kiingereza)

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  • AM Diabetes & Endocrinology Center- Site Number : 8400004, Bartlett
InaajiriHatua 3
Umri 1 hadi 25 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • University Diabetes & Endocrine Consultants, Chattanooga
  • Le Bonhuer Children's, Memphis
InaajiriHatua 1/2
Umri 12 hadi 35 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06783309

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  • Vanderbilt University, Nashville
InaajiriHatua 2
Umri 8 hadi 45 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07142252

Family Intervention for Black Teens With Type 1 Diabetes

  • LeBonheur Children's Hospital, Memphis
  • University of Tennessee Health Science Center-Memphis, Memphis
Inaajiri
Umri 10 hadi 14 · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT06275412

Registry for Stage 2 Type 1 Diabetes

  • AM Diabetes & Endocrinology Center- Site Number : 8400012, Bartlett
  • Vanderbilt University Medical Center- Site Number : 8400023, Nashville
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 13 Apr 2026 · NCT06481904

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

  • Vanderbilt University Medical Center, Nashville
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Mac 2026 · NCT06852950

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

  • Vanderbilt University Medical Center, Nashville
InaajiriHatua ya kwanza ya awaliWajitolea wenye afya wanakaribishwa
Umri 18 hadi 60 · Jinsia zote · Imesasishwa 23 Des 2025 · NCT06609356

Discovery Diabetes

  • Vanderbilt University, Nashville
Inaajiri
Umri 13 hadi 21 · Jinsia zote · Imesasishwa 23 Des 2025 · NCT07116434

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

  • Vanderbilt University Medical Center, Nashville
InaajiriHatua ya kwanza ya awali
Umri 12 hadi 50 · Jinsia zote · Imesasishwa 18 Des 2025 · NCT06338553

Sleep Coach for Adolescents With Type 1 Diabetes

  • Vanderbilt University Medical Center, Nashville
Inaajiri
Umri 11 hadi 17 · Jinsia zote · Imesasishwa 1 Okt 2025 · NCT06516614

TrialNet Pathway to Prevention of T1D

  • Vanderbilt University, Nashville
InaajiriUtafiti wa uchunguziWajitolea wenye afya wanakaribishwa
Umri 2 hadi 45 · Jinsia zote · Imesasishwa 1 Jul 2025 · NCT00097292

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.